CDC endorses Moderna's COVID vaccine for kids 6 to 17 years old
Yahoo Finance's Rachelle Akuffo looks at Moderna's stock following a CDC panel's endorsement of its latest vaccine.
Video Transcript
RACHELLE AKUFFO: Well, before we go to a break, let's take a look at shares of Moderna. The CDC advisory panel endorsing the company's two-dose COVID vaccine for children ages 6 to 17 years old. The vaccine is expected to get full approval later today. The stock up almost 4 and 1/2%.